Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19201909rdf:typepubmed:Citationlld:pubmed
pubmed-article:19201909lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:19201909lifeskim:mentionsumls-concept:C0030498lld:lifeskim
pubmed-article:19201909lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:19201909lifeskim:mentionsumls-concept:C0024432lld:lifeskim
pubmed-article:19201909lifeskim:mentionsumls-concept:C0023283lld:lifeskim
pubmed-article:19201909lifeskim:mentionsumls-concept:C1420306lld:lifeskim
pubmed-article:19201909lifeskim:mentionsumls-concept:C0162388lld:lifeskim
pubmed-article:19201909lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:19201909pubmed:issue4lld:pubmed
pubmed-article:19201909pubmed:dateCreated2009-2-9lld:pubmed
pubmed-article:19201909pubmed:abstractTextType I IFNs (IFN-alpha/beta) have only recently gained considerable attention as immunomodulators in nonviral infectious diseases. IFN-beta has been shown to protect, in a NO-dependent manner, against murine Old World leishmaniasis caused by Leishmania major, but data in New World leishmaniasis are lacking. We found that IFN-beta dose-dependently increases parasite burden in Leishmania amazonensis- as well as Leishmania braziliensis-infected human macrophages, independent of endogenous or exogenous NO. However, IFN-beta significantly reduced superoxide release in Leishmania-infected as well as uninfected human macrophages. This decrease in superoxide production was paralleled by a significant IFN-beta-mediated increase in superoxide dismutase 1 (SOD1) protein levels. Additionally, IFN-beta inhibition of leishmanicidal activity was mimicked by SOD1 and antagonized by either pharmacological or small interfering RNA-mediated inhibition of SOD1. Finally, pronounced SOD1 expression in situ was demonstrated in biopsies from New World cutaneous leishmaniasis patients. These findings reveal a hitherto unknown IFN-beta/SOD1 axis in Leishmania infection and suggest that inhibition of SOD-associated pathways could serve as strategy in the treatment of L. amazonensis as well as L. braziliensis infection, major human pathogens.lld:pubmed
pubmed-article:19201909pubmed:languageenglld:pubmed
pubmed-article:19201909pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19201909pubmed:citationSubsetAIMlld:pubmed
pubmed-article:19201909pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19201909pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19201909pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19201909pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19201909pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19201909pubmed:statusMEDLINElld:pubmed
pubmed-article:19201909pubmed:monthFeblld:pubmed
pubmed-article:19201909pubmed:issn1550-6606lld:pubmed
pubmed-article:19201909pubmed:authorpubmed-author:Barral-NettoM...lld:pubmed
pubmed-article:19201909pubmed:authorpubmed-author:WietzerbinJua...lld:pubmed
pubmed-article:19201909pubmed:authorpubmed-author:BarralAldinaAlld:pubmed
pubmed-article:19201909pubmed:authorpubmed-author:Van...lld:pubmed
pubmed-article:19201909pubmed:authorpubmed-author:KolbJean-Pier...lld:pubmed
pubmed-article:19201909pubmed:authorpubmed-author:BaficaAndréAlld:pubmed
pubmed-article:19201909pubmed:authorpubmed-author:KhouriRicardo...lld:pubmed
pubmed-article:19201909pubmed:authorpubmed-author:SilvaMaria...lld:pubmed
pubmed-article:19201909pubmed:authorpubmed-author:NoronhaAlmeri...lld:pubmed
pubmed-article:19201909pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19201909pubmed:day15lld:pubmed
pubmed-article:19201909pubmed:volume182lld:pubmed
pubmed-article:19201909pubmed:ownerNLMlld:pubmed
pubmed-article:19201909pubmed:authorsCompleteYlld:pubmed
pubmed-article:19201909pubmed:pagination2525-31lld:pubmed
pubmed-article:19201909pubmed:meshHeadingpubmed-meshheading:19201909...lld:pubmed
pubmed-article:19201909pubmed:meshHeadingpubmed-meshheading:19201909...lld:pubmed
pubmed-article:19201909pubmed:meshHeadingpubmed-meshheading:19201909...lld:pubmed
pubmed-article:19201909pubmed:meshHeadingpubmed-meshheading:19201909...lld:pubmed
pubmed-article:19201909pubmed:meshHeadingpubmed-meshheading:19201909...lld:pubmed
pubmed-article:19201909pubmed:meshHeadingpubmed-meshheading:19201909...lld:pubmed
pubmed-article:19201909pubmed:meshHeadingpubmed-meshheading:19201909...lld:pubmed
pubmed-article:19201909pubmed:meshHeadingpubmed-meshheading:19201909...lld:pubmed
pubmed-article:19201909pubmed:meshHeadingpubmed-meshheading:19201909...lld:pubmed
pubmed-article:19201909pubmed:meshHeadingpubmed-meshheading:19201909...lld:pubmed
pubmed-article:19201909pubmed:year2009lld:pubmed
pubmed-article:19201909pubmed:articleTitleIFN-beta impairs superoxide-dependent parasite killing in human macrophages: evidence for a deleterious role of SOD1 in cutaneous leishmaniasis.lld:pubmed
pubmed-article:19201909pubmed:affiliationLaboratory of Immunoregulation and Microbiology, Centro de Pesquisa Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador- Bahia, Brazi.lld:pubmed
pubmed-article:19201909pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19201909pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:3456entrezgene:pubmedpubmed-article:19201909lld:entrezgene
entrez-gene:6647entrezgene:pubmedpubmed-article:19201909lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19201909lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19201909lld:entrezgene
lhgdn:association:14662lhgdn:found_inpubmed-article:19201909lld:lhgdn
lhgdn:association:24712lhgdn:found_inpubmed-article:19201909lld:lhgdn
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19201909lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19201909lld:pubmed